Take-Off 2 for 3D miniature heartCardiovascular disease is the No. 1 cause of death worldwide. There is no cure yet for many of these conditions. Ninety-one percent of newly developed drugs do not make it through clinical trials, as tests in animals and 2D models are unable to simulate human heart function reliably. The UT spin-off River BioMedics is working on 3D models of the heart that can do this, and today the company is being awarded Take-Off Phase 2 for early-phase projects by the Dutch Research Council (NWO) and the Netherlands Organisation for Health Research and Development (ZonMw).Read more
New nanosensor detects cancer biomarkers in drop of bloodLooking for cancer biomarkers in blood is a promising method for detecting metastatic cancer. It is less demanding than imaging techniques like MRI (magnetic resonance imaging). The main challenge to overcome is the extremely low concentrations of these markers making it difficult to detect them. Researchers of the University of Twente and Wageningen University developed a nanosensor able to accurately detect biomarkers for cancer in an extremely broad range of concentrations: from 10 particles per microliter to a million particles per microliter. With their nanosensor, the researchers made it to the cover of Nano Letters, a journal of the American Chemical Society.Read more
Take-Off 2 for 3D miniature heart
New nanosensor detects cancer biomarkers in drop of blood
Call for speakers NWO Bessensap 2020
Tracking tumour cells and unraveling hidden information
Nathalie Katsonis and Tibor Kudernac are leaving the UT
Avoiding bubble troubles
New material for cleaner contact lenses
Waves of ice inside a droplet
Just have a look at light that is forbidden
Start research to improved treatment of cardiac arrhythmia
New technology makes green filtering possible
Using light to encrypt communications
